Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
P27 The role of AI tools in supporting cardiovascular lifestyle behaviour change
0
Zitationen
5
Autoren
2025
Jahr
Abstract
<h3>Background</h3> Cardiovascular disease (CVD) remains a leading cause of death globally, primarily driven by modifiable lifestyle risk factors. Artificial Intelligence (AI) tools, such as chatbots and virtual assistants, offer a promising approach to improve patient education and self-management. However, their role in CVD prevention and lifestyle behaviour change underexplored. <h3>Aim</h3> To explore the potential of AI tools in promoting lifestyle behaviour change and mental health among individuals with CVD, and to understand nurses’ perspectives on their integration into care pathways. <h3>Methods</h3> Following the Appreciative Inquiry 4D Cycle, this study represents the 1<sup>st</sup> Phase (Discovery) of a proposed larger project and consists of two components (figure 1): 1. A scoping review (currently underway) conducted using Joanna Briggs Institute methodology to systematically map existing literature on the use of AI tools for CVD-related lifestyle behaviour change. The review will explore types of AI tools, behavioural outcomes, evaluation methods, evidence gaps, and directions for future research. 2. A qualitative study involving semi-structured interviews with 30 nurses (in training and practice), recruited via universities and professional networks in the United Kingdom (UK). Using the RE-AIM framework, interviews will explore experiences, expectations, and perceived barriers and facilitators to AI adoption in CVD care. Data will be analysed thematically using NVivo. <h3>Results</h3> The study will summarise the current evidence base and identify key gaps, particularly related to the real-world usability and implementation challenges of AI tools in supporting lifestyle change for CVD. Findings will inform subsequent phases of research, including the co-design and testing of an AI prototype for CVD lifestyle modification. <h3>Conclusion</h3> This study will generate foundational insights into the role of AI in cardiovascular risk management and inform the development of a personalised AI tool. Findings from the scoping review and qualitative study will be presented at the conference.
Ähnliche Arbeiten
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
2004 · 11.838 Zit.
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
2020 · 10.453 Zit.
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
2021 · 9.157 Zit.
Heart Disease and Stroke Statistics—2012 Update
2011 · 7.221 Zit.
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
2018 · 7.143 Zit.